The RISE study protocol: resilience impacted by positive stressful events for people with cystic fibrosis

INTRODUCTION: For people with cystic fibrosis (CF), gaining access to elexacaftor/tezacaftor/ivacaftor (ETI) therapy, a new modulator drug combination, is perceived as a positive life event. ETI leads to a strong improvement of disease symptoms. However, some people with CF experience a deterioratio...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Heijden, Els, van den Bor, Rutger M., van der Ent, Cornelis K., Nijhof, Sanne L., van der Laan, Sabine E.I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Study Protocols
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258717/
https://www.ncbi.nlm.nih.gov/pubmed/37313395
http://dx.doi.org/10.1183/23120541.00535-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258717/
https://www.ncbi.nlm.nih.gov/pubmed/37313395
http://dx.doi.org/10.1183/23120541.00535-2022

Ejemplares similares